Top 15 Most Read* Value in Health Articles

*Below are the 15 most popular articles for this journal on Blackwell Synergy, based on the Journal Citation Reports of Information Sciences Institute (ISI) as of January 3, 2008. The top 15 Most Read and Cited articles rankings are compiled from all Value in Health issues since May/June 1998, Vol. 1, Issue 1.

1. Odds Ratio, Relative Risk, Absolute Risk Reduction, and the Number Needed to Treat—Which of These Should We Use?
   Edna Schechtman PhD 
   Value in Health, Volume 5 Issue 5 Page 431-436 Sep 2002
   ABSTRACT
    
2. Cost-Effectiveness versus Cost–Utility Analysis of Interventions for Cancer: Does Adjusting for Health-Related Quality of Life Really Matter?
   Tammy O. Tengs ScD
   Value in Health Volume 7 Issue 1 Page 70-78 Jan 2004
   ABSTRACT
   
   
3. The Clinical Characteristics and Impact of Laryngopharyngeal Reflux Disease on Health-Related Quality of Life
   William R. Lenderking, PhD, Eric Hillson, PhD, Joseph A. Crawley,MS, David Moore,MD, Richard Berzon,DrPH, Chris L. PashosPhD
   Value in Health, Volume 6 Issue 5 Page 560-565 Sep 2003
   ABSTRACT
    
4. Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
   Louis S. Matza PhD, Andrine R. Swensen MSPhD, Emuella M. Flood BA, Kristina Secnik PhD, Nancy Kline Leidy PhD
   Value in Health, Volume 7 Issue 1 Page 79-92 Jan 2004
   ABSTRACT
   
   
5. Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?
   Hans-Georg Eichler, MD, MS, Sheldon X. Kong, PhD, William C. Gerth, MBA, Panagiotis Mavros, PhD, Bengt Jönsson, PhD
   Value in Health, Volume 7 Issue 5 Page 518-528 Sep 2004
   ABSTRACT
    
6. A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
   Andrew M. Peterson, PharmD, David P. Nau, PhD, Joyce A. Cramer, BS, Josh Benner, PharmD, ScD, Femida Gwadry-Sridhar, PhD, RPh, MSc, BSc, Michael Nichol, PhD
   Value in Health, Volume 10 Issue 1 Page 3-12 Jan 2007
   ABSTRACT
    
7. Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial
   Sandra L. Tunis, PhD, Douglas E. Faries, PhD, Allen W. Nyhuis, MS, Bruce J. Kinon, MD, Haya Ascher-Svanum, PhD, Ralph Aquila, MD
   Value in Health, Volume 9 Issue 2 Page 77-89 Mar 2006
   ABSTRACT
    
8. Age-Specific Impact of Obesity on Prevalence and Costs of Diabetes and Dyslipidemia
   Eric A. Finkelstein, PhD, Derek S. Brown, PhD, Justin G. Trogdon, PhD, Joel E. Segel, BA, Rami H. Ben-Joseph, PhD Value in Health, Volume 10 Issue s1 Page S45-S51 Jan 2007
   ABSTRACT
    
9. Too Much Ado about Propensity Score Models? Comparing Methods of Propensity Score Matching
   Onur Baser, PhD
   Value in Health, Volume 9 Issue 6 Page 377-385 Nov 2006
   ABSTRACT
    
10. Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles
    J. Jaime Caro, MDCM, FRCPC, FACP, Judith A. O’Brien, RN, Christopher S. Hollenbeak, PhD, Eldon Spackman, MA, Rami Ben-Joseph, PhD, Lynn J. Okamoto, PharmD, L. Clark Paramore, MSPH
    Value in Health, Volume 10 Issue s1 Page S12-S20 Jan 2007
    ABSTRACT
     
11. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis
    Josephine A. Mauskopf, PhD, Sean D. Sullivan, PhD, Lieven Annemans, PhD, MSc, Jaime Caro, MD, C. Daniel Mullins, PhD, Mark Nuijten, PhD, MBA, MD, Ewa Orlewska, MD, PhD, John Watkins, RPh, MPH, Paul Trueman, MA, BA
    Value in Health, Volume 10 Issue 5 Page 336-347 Sep 2007
    ABSTRACT
     
12. Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
    Scott Ramsey, MD, PhD (cochair), Richard Willke, PhD (cochair), Andrew Briggs, DPhil, Ruth Brown, MS, Martin Buxton, PhD, Anita Chawla, PhD, John Cook, PhD, Henry Glick, PhD, Bengt Liljas, PhD, Diana Petitti, MD, Shelby Reed, PhD
    Value in Health, Volume 8 Issue 5 Page 521-533 Sep 2005
    ABSTRACT
     
13. Exploring Cardiometabolic Complications of Obesity and Related Risk Factors: Prevalence and Economic Consequences
    Value in Health, Volume 10 Issue s1 Page i-i Jan 2007
    SUMMARY
     
14. The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model
    Samuel Aballéa, MSc, Jeremy Chancellor, MSc, Monique Martin, MSc, Peter Wutzler, MD, Fabrice Carrat, MD, PhD, Roberto Gasparini, MD, Joao Toniolo-Neto, MD, Michael Drummond, DPhil, Milton Weinstein, PhD
    Value in Health, Volume 10 Issue 2 Page 98-116 Mar 2007
    ABSTRACT
     
15. Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy
    Susan Moore, MD, MPH, John Tumeh, BA, Steven Wojtanowski, RPh, MPH, Christopher Flowers, MD, MS
    Value in Health, Volume 10 Issue 1 Page 23-31 Jan 2007
    ABSTRACT

Value in Health Main Page